{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:40:18Z","timestamp":1760985618791},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1984,8,1]],"date-time":"1984-08-01T00:00:00Z","timestamp":460166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Clinical Nutrition"],"published-print":{"date-parts":[[1984,8]]},"DOI":"10.1093\/ajcn\/40.2.277","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T12:14:57Z","timestamp":1515586497000},"page":"277-284","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["The design of a diet restricted in saturated very long-chain fatty acids: therapeutic application in adrenoleukodystrophy"],"prefix":"10.1016","volume":"40","author":[{"given":"M A","family":"Van Duyn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A E","family":"Moser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"F R","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Sacktor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H W","family":"Moser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/ajcn\/40.2.277_bib1","first-page":"577","article-title":"et al.","volume":"32","author":"Schaumburg","year":"1975","journal-title":"Adrenoleukodystrophy: a clinical and pathological study of 17 cases. Arch Neurol"},{"key":"10.1093\/ajcn\/40.2.277_bib2","first-page":"851","article-title":"et al.","volume":"26","author":"Igarashi","year":"1976","journal-title":"Fatty acid abnormality in adrenoleukodystrophy. J Neuro-chem"},{"key":"10.1093\/ajcn\/40.2.277_bib3","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1212\/WNL.27.10.928","article-title":"Adrenoleukodystrophy: accumulation of cholesterol esters with very long chain fatty acids.","volume":"27","author":"Menkes","year":"1977","journal-title":"Neurology"},{"key":"10.1093\/ajcn\/40.2.277_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-510X(79)90203-X","article-title":"Adrenoleukodystrophy: brain cholesterol esters and other neutral lipids.","volume":"40","author":"Ramsey","year":"1979","journal-title":"J Neurol Sci"},{"key":"10.1093\/ajcn\/40.2.277_bib5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0022-510X(81)90108-8","article-title":"Accumulation of very long chain fatty acids is common to 3 variants of adrenoleukodystrophy (ALD) \u201cchemical\u201d ALD, atypical ALD (female patient) and adrenomyeloneuropathy.","volume":"51","author":"Molzer","year":"1981","journal-title":"J Neurol Sci"},{"key":"10.1093\/ajcn\/40.2.277_bib6","doi-asserted-by":"crossref","unstructured":"Moser HW, Moser AB, Kawamura N, et al. Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts. Ann Neurol 1980;7:542-9.","DOI":"10.1002\/ana.410070607"},{"key":"10.1093\/ajcn\/40.2.277_bib7","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1212\/WNL.31.10.1241","article-title":"Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids.","volume":"31","author":"Moser","year":"1981","journal-title":"Neurology"},{"key":"10.1093\/ajcn\/40.2.277_bib8","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1471-4159.1981.tb01698.x","article-title":"Abnormality of long chain fatty acids in erythrocyte membrane sphingomyelin from patients with adrenoleukodystrophy.","volume":"36","author":"Tsuji","year":"1981","journal-title":"J Neu-rochem"},{"key":"10.1093\/ajcn\/40.2.277_bib9","doi-asserted-by":"crossref","unstructured":"Molzer B, Bernheimer H, Heller R, Toifl K, Vetterlein M. Detection of adrenoleukodystrophy by increased C26:0 fatty acid levels in leukocytes. Clin Chim Acta 1982;125:299-305.","DOI":"10.1016\/0009-8981(82)90260-1"},{"key":"10.1093\/ajcn\/40.2.277_bib10","doi-asserted-by":"crossref","unstructured":"Singh 1, Moser HW, Moser AB, Kishimoto Y. Adrenoleukodystrophy: impaired oxidation of long chain fatty acids in cultured skin fibroblasts and adrenal cortex. Biochem Biophys Res Commun 1981;102:1223-9.","DOI":"10.1016\/S0006-291X(81)80142-8"},{"key":"10.1093\/ajcn\/40.2.277_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0006-291X(80)91182-1","article-title":"Adrenoleukodystrophy: evidence that abnormal very long chain fatty acids of brain cholesterol esters are of exogenous origin.","volume":"96","author":"Kishimoto","year":"1980","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1093\/ajcn\/40.2.277_bib12","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0014-5793(78)80399-8","article-title":"Biosynthesis of very long chain fatty acids by the sciatic nerve of the rabbit.","volume":"90","author":"Cassagne","year":"1978","journal-title":"FEBS Lett"},{"key":"10.1093\/ajcn\/40.2.277_bib13","unstructured":"Steinberg D. Phytanic acid storage disease (Refsum\u2019s disease). In: Stauburg JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS, eds. The metabolic basis of inherited disease. 5th ed. New York, NY: McGraw Hill, 1983,731-47."},{"key":"10.1093\/ajcn\/40.2.277_bib14","unstructured":"Hilditoh TP, Williams PN. The chemical constitution of natural fats. New York, NY: John Wiley ASonsInc, 1964."},{"key":"10.1093\/ajcn\/40.2.277_bib15","first-page":"164","article-title":"et al.","volume":"151","author":"Brown","year":"1982","journal-title":"Adrenoleukodystrophy: effects of dietary restriction of very long chain fatty acids and of administration of carnitine and colfibrate on clinical status and plasma fatty acids. Johns Hopkins Med J"},{"key":"10.1093\/ajcn\/40.2.277_bib16","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1104\/pp.54.5.670","article-title":"Structure and biosynthesis of cuticular lipids.","volume":"54","author":"Kolattukudy","year":"1974","journal-title":"Plant Physiol"},{"key":"10.1093\/ajcn\/40.2.277_bib17","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/0006-291X(70)90567-X","article-title":"The function of very long chain fatty acids in membrane structure: evidence from milk cerebrosides.","volume":"41","author":"Kayser","year":"1970","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1093\/ajcn\/40.2.277_bib18","doi-asserted-by":"crossref","unstructured":"Tsuji S, Sano T, Ariga T, Miyatake T. Increased synthesis of hexacosanoic acid (C26:0) by cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN). J Biochem 1981;90:1233-6.","DOI":"10.1093\/oxfordjournals.jbchem.a133578"},{"key":"10.1093\/ajcn\/40.2.277_bib19","article-title":"Adrenoleukodystrophy: origin of very long chain fatty acids and therapy.","volume":"17","author":"Moser","year":"1983","journal-title":"Pediatr Res"},{"key":"10.1093\/ajcn\/40.2.277_bib20","first-page":"313","article-title":"et al.","volume":"46","author":"Steinberg","year":"2019","journal-title":"Studies on the metabolic error in Refsum\u2019s disease. J Clin Invest"},{"key":"10.1093\/ajcn\/40.2.277_bib21","article-title":"Bone marrow transplant inadrenoleukodystrophy.","volume":"33","author":"Moser","year":"1983","journal-title":"Neurology"}],"container-title":["The American Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523243853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523243853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ajcn\/article-pdf\/40\/2\/277\/23312422\/277.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T06:30:26Z","timestamp":1686292226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002916523243853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,8]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1984,8]]}},"alternative-id":["S0002916523243853"],"URL":"https:\/\/doi.org\/10.1093\/ajcn\/40.2.277","relation":{},"ISSN":["0002-9165"],"issn-type":[{"value":"0002-9165","type":"print"}],"subject":[],"published":{"date-parts":[[1984,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The design of a diet restricted in saturated very long-chain fatty acids: therapeutic application in adrenoleukodystrophy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/ajcn\/40.2.277","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1984 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}